Background. Adults with the tick-borne disease human granulocytic anaplasmosis (HGA) have a spectrum of acute febrile illnesses that, if untreated, might be severe. Clinical presentation and outcomes of children with HGA have been poorly described.
Human granulocytic anaplasmosis (HGA) is an emerging tickborne disease caused by the intracellular bacterium Anaplasma phagocytophilum [1, 2] . The pathogen is transmitted in the United States by the blacklegged ticks Ixodes scapularis and Ixodes pacificus, which also are the primary vectors for Borrelia burgdorferi (the etiologic agent of Lyme disease), Babesia microti, Powassan virus, and the recently discovered agents Ehrlichia muris-like sp., Borrelia miyamotoi, and Borrelia mayonii [3] [4] [5] . Since the discovery of HGA in 1994 [6] , the incidence of reported cases in the United States has increased annually, with a notable 52% increase in cases between 2009 and 2010 [7] ; passive surveillance identified 6.3 cases per million person-years for 2008-2012 [8] . HGA is reported most frequently from the upper Midwest and northeastern United States [1, 8] ; estimates in some regions of Wisconsin exceed 120 cases per 100 000 population [9] .
Diagnosis of HGA is challenging because symptoms of infection are nonspecific; most infected adults present with fever, severe headache, malaise, and myalgia. Thrombocytopenia and elevated liver transaminase levels are common, and neutropenia affects approximately half of infected adults [10, 11] . Life-threatening complications might occur in 3% to 6% of infected patients [1, 8] , and the symptoms, including septic-like shock, neuropathy, respiratory or renal failure, and pancarditis [1, 8, 10, 11] , are also nonspecific and consistent with a systemic inflammatory response. Nearly one-third of infected patients require hospitalization, although current estimates propose that less than 1% of cases are fatal [1, 8] . Polymerase chain reaction (PCR) tests are now available to confirm clinical suspicion of HGA. Diagnosis might also be aided by the identification of morulae on blood smears by experienced pathologists or the detection of elevated antibody levels by serologic tests, although the clinical utility of these tests is limited by their lower sensitivities in the acute phase of infection and in the inability of serologic tests to differentiate between active infection and past exposure [8, [12] [13] [14] .
Although the results of epidemiologic studies have suggested that HGA is uncommon in children [15, 16] , the clinical presentation and severity of disease in and the outcomes of children with HGA are largely unknown. In our literature search, we were unable to find any comprehensive studies that reported specifically on HGA in children. In this retrospective study, we determined the annual frequency of HGA in children in a region of northern Wisconsin in which HGA is highly endemic over a 21-year study period, and we describe here the clinical features and outcomes of children with confirmed and those with probable HGA infection. A retrospective chart review was completed to validate HGA diagnoses and to abstract patient data, including demographics, clinical signs and symptoms, laboratory and diagnostic studies, the clinical course, treatment, and outcomes. Patients were considered to be positive for fever if they had reported fever, sweats, or chills or if their clinical temperature was ≥100.3°F at any time during their illness. We used the CDC case definition [17] (Table 1) to classify cases as confirmed, probable, or suspected and calculated descriptive statistics for the patients in these categories. Patients were evaluated for possible coinfection with Lyme disease if they had a physician-diagnosed and -described erythema migrans (EM) rash or positive 2-tier serologic testing results, as recommended by the CDC [18] , and for babesiosis coinfection if they had parasites visible on a blood smear examination, a positive PCR test result for B microti, or a B microti antibody titer of ≥1:256 [19] .
METHODS

Patients
Quality assurance of abstracted data was assessed on 20% of all possible case records. Suspected cases of HGA were included in our epidemiologic analyses for descriptive purposes only. Clinical features and outcomes were compared between patients with confirmed and those with probable HGA and between patients with evidence of HGA only and those with evidence of HGA and Lyme disease coinfection. Categorical variables were compared using the Fisher's exact test. Continuous variables were compared using the Wilcoxon rank-sum test. Odds ratios (ORs) were calculated for pertinent variables. Statistical analysis was completed using SAS 9.3 (SAS Institute, Inc., Cary, NC). Significance was defined at a P value of < .05.
Our research protocols were approved by the Institutional Review Board of Marshfield Clinic Research Institute. A waiver of informed consent was obtained for this retrospective review and analysis of clinical and laboratory information.
RESULTS
Our query identified 232 patients with possible HGA. In total, 187 (81%) patients had sufficient clinical and laboratory evidence available to be included in our analyses. Of these patients, 17 (9%) met the CDC definition for confirmed infection, 75 (40%) for probable infection, and 91 (49%) for suspected infection. Four (2%) patients had laboratory-confirmed evidence of infection but did not meet CDC criteria for clinically compatible disease. These patients were combined with the confirmed cases in our epidemiologic and diagnostic data analyses but were considered separately in our clinical analyses.
The first pediatric patient who met the case criteria for HGA presented in 1996. Between 1996 and 2009, the median number of patients with HGA per year was 2 (range, 0-7). In 2010-2015, the median number of cases per year increased substantially to 25 (range, (Figure 1 ). Onset of illness in every month of the year was reported, but most patients (69% of 160 with onset In our study, the majority of patients classified as having suspected infection (92%) had clinical information available, but their presentation did not meet the definition for clinically compatible disease or was not documented adequately to determine as such.
data) became ill between May and August, when ticks are highly active in Wisconsin.
The majority (81%) of confirmed cases were diagnosed by PCR; only 4 (19%) patients were diagnosed using serologic evidence. The probable and suspected cases were diagnosed primarily by serology (97% and 98%, respectively); only 3 patients had positive blood smear results (Table 2) . One patient with probable infection had a PCR test result reported as equivocal. Most of the patients with probable or suspected infection had a single elevated titer for A phagocytophilum, although 15 (9%) of them did have a repeated positive titer that failed to meet the 4-fold change required to be classified as confirmed infection. Patients with suspected infected were more likely than those with probable infection to have a single titer at 1:64, the lowest titer considered positive (OR, 2.13 [95% CI, 1.08-4.20]). Patients with suspected infection also tended to seek care later in their illness (median [interquartile range (IQR)] intervals, 3 [2] [3] [4] [5] [6] [7] , 4.5 [2] [3] [4] [5] [6] [7] [8] [9] [10] , and 14 days for confirmed, probable, and suspected infection, respectively; P < .001, Wilcoxon rank-sum test) and were the least likely to report a tick bite or exposure (27% vs 82% and 59%, suspected vs confirmed and probable infection, respectively) ( Table 2) .
The percentage of patients tested for HGA by PCR in the time period after the availability of the test by the clinical diagnostic laboratory at the Marshfield Clinic (2013-2015) increased significantly from 5% to 42% (P < .001). The increased use of PCR diagnosis resulted in a significantly higher percentage of HGA cases being classified as confirmed in this period (P < .001); however, most patients in our cohort (58%) still were not tested by PCR.
The ages of patients with HGA ranged from 17 months to 18 years (median, 12 years [IQR, [8] [9] [10] [11] [12] [13] [14] [15] [16] years]); patients with confirmed or probable infection were slightly younger than those with suspected infection (P = .050) (Figure 2 ). More patients with HGA (59% overall) were female. We found no differences between the ages of girls and boys in the case categories (all P ≥ .610, Wilcoxon Rank-sum test).
Significantly more patients with confirmed infection had a lower white blood cell count and leukopenia, a lower platelet count, and a lower C-reactive protein (CRP) level than those with probable infection (Table 3) . Overall, the majority of those with confirmed or probable infection presented with fever (100%), headache (71%), and myalgia (64%). Fatigue also was common (55% of patients). Only for 8% of these patients was evidence of anemia found, although 24% of them presented with leukopenia and 17% presented with thrombocytopenia. An elevated liver transaminase level was present in 33% of the patients tested with confirmed or probable infection. The majority (66%) of patients with confirmed or probable infection also had an elevated CRP level (n = 32). Significantly more patients with confirmed than with probable infection reported a (Table  3) . Three patients with probable HGA had concurrent positive infectious mononucleosis antibody tests, and 1 patient had a positive strep throat culture. Overall, clinical or serologic evidence of coinfection with Lyme disease was found in 22 (27%) of the patients in the confirmed-or probable-infection group (Table 3) . Five of these patients presented with EM only, 3 presented with EM and had positive 2-tier serology results, and 14 had no EM but had positive 2-tier serology results. With the exception of 1 confirmed case of HGA in a patient who had positive Lyme IgM and IgG immunoblot results, all other patients with positive Lyme 2-tier serology results had positive Lyme IgM immunoblot results. Evidence of babesiosis coinfection was found in none of our patients with HGA. We found few differences in the clinical features of the patients with confirmed or probable HGA with evidence of Lyme disease coinfection and those who had only HGA (Table 4) . Patients for whom evidence of Lyme disease coinfection was found were significantly less likely to present with leukopenia than the patients with HGA only (exact OR 0.00, [95% CI, 0.00-0.40]). Thrombocytopenia also was less common in patients in whom evidence of Lyme disease coinfection was found, although this result was not statistically significant (OR, 0.28 [95%, 0.033-2.37]). Patients in whom evidence of Lyme disease coinfection was found were more likely to be hospitalized than non-coinfected patients (OR, 6.55 [95% CI, 1.11-38.78]). History of tick exposure or bite was approximately 55% in both groups (Table 4) .
Of the 4 patients who had a positive PCR test result for A phagocytophilum but whose condition failed to meet the CDC clinical definition, only 1 reported fever; this patient also reported fatigue, and evidence of Lyme disease coinfection with a positive 2-tier serology test (IgM immunoblot positive) was found, but the patient was negative for all other symptoms, including having normal blood cell counts and liver transaminase levels at the time of presentation. Of the other 3 patients with PCR-positive results, 1 complained of headaches, fatigue, and sore throat and had a positive strep throat culture. Few symptoms were documented in the records of the remaining 2 patients, but they both presented with evidence suggestive of Lyme disease coinfection; 1 patient had joint pain and a positive Lyme enzyme immunoassay result, but no results from Lyme immunoblots were available for this patient, and the other patient presented with a rash consistent with EM, an equivocal Lyme enzyme immunoassay result, and negative immunoblot results.
All of the patients with confirmed infection and the majority (96%) of those with probable infection were treated for HGA. Doxycycline was prescribed for 76 (85%) of the patients with confirmed or probable infection, rifampin was prescribed for 1 (1%), and both rifampin and doxycycline were given to 2 (2%) patients. Six (7%) patients with confirmed or probable disease required hospitalization. No patients required intensive care unit care or died. Adverse outcomes did not occur in any of the 15 (8%) patients with probable or suspected infection who were not prescribed treatment.
DISCUSSION
Epidemiologic studies have found infrequent occurrence of HGA in pediatric patients [15, 16, 20] , unlike Lyme disease, for which a high risk of infection in children is known [15, 21] . Although we have not performed a comparable retrospective study in the adult population at the MCHS to determine if the frequency of HGA in children is different from that in adults, a review of our system's laboratory test records for our study period indicated that approximately 0.9% of PCR or blood smear tests for A phagocytophilum performed for children (n = 2340) had positive or equivocal results versus 3.1% of those tests in adults (n = 19 054), which suggests that HGA might indeed occur less frequently in children. However, our results also suggest that the frequency of this disease in children might be increasing. In particular, since 2009, the number of pediatric HGA cases rose nearly 4-fold, mirroring an increase in HGA cases observed in Wisconsin and the nation [7, 9] . The increase might be related to greater awareness of the disease and improved availability of testing but also likely reflects the expansion of the I scapularis tick population in Wisconsin [22, 23] . The prevalence of A phagocytophilum infection in adult I scapularis ticks in Wisconsin is estimated to be approximately 8% in contrast to as high as 44% for B burgdorferi, which would partially explain the lower prevalence of HGA than of Lyme disease in the state [24] .
Results of epidemiologic studies have also suggested that children are less susceptible to HGA than adults [1, 15] . The severity of HGA in adults is correlated with age; people older than 70 years are at greatest risk of experiencing life-threatening complications [1, 8, 14] . Our data support this notion, in that few children identified in our analysis presented with severe HGA. Only approximately 20% of the children in our cohort presented with leukopenia or thrombocytopenia, and elevated liver transaminase levels were present in approximately one-third of the patients, whereas these abnormalities occur in 50% to 75% of infected adults [10, 11] . Similar to results of adult studies, the majority of pediatric patients with confirmed or probable HGA infection presented with fever, headache, myalgia, and fatigue; approximately one-third of the patients had gastrointestinal symptoms, and one-fourth of them had cough [2, 11] . Lending further support to the hypothesis that children are less susceptible to HGA, and therefore are more likely to have subclinical or mild manifestations of the disease than adults, was the observation that the condition of many patients failed to meet the clinical definition for HGA despite laboratory evidence of infection being found. For instance, 4 cases with a positive PCR test result failed to meet the clinical definition because of lack of fever or other symptoms, and only 7% of the 84 patients with suspected infection for whom clinical notes were available had evidence of fever documented in their history. The large number of suspected infections, however, also likely reflects a degree of inappropriate testing in children whose illness is unlikely to be HGA, because the majority of these patients had low elevated titers for A phagocytophilum and did not report a tick bite or tick exposure. Only 6 (7%) children in our study were hospitalized, and we found no indication that the rate of hospitalization was higher in younger children (risk of hospitalization in children <9 years old: OR, 1.65 [95% CI, 0.36-7.64]). More important, however, is that all but 1 of the hospitalized patients were diagnosed with HGA on the basis of a single elevated antibody titer, which limits our ability to know if hospitalization occurred because of complications related to active HGA or other factors. Other such factors that might influence the severity of HGA include underlying immunosuppressive conditions or comorbidities and coinfection with other tick-borne diseases [1, 8, 11] . Indeed, all of the patients in our study who were hospitalized had another underlying condition, including 4 patients with evidence of Lyme disease coinfection. A fifth hospitalized patient presented with persistent fever, lymphadenopathy, and muscle pain, and had serologic evidence of infectious mononucleosis and possible urinary tract infection; the sixth patient was admitted for fever and dehydration after several days of vomiting and diarrhea, and Blastocystis hominis was detected in his stool. Although evidence of HGA and Lyme disease coinfection was a significant risk factor for hospitalization, we found no evidence that disease severity was greater in patients suspected of being coinfected. On the contrary, patients with coinfection were less likely to present with leukopenia and, to some degree, thrombocytopenia than patients with evidence of only HGA. Similar results were found in a study that compared signs and symptoms of adults with evidence of HGA and Lyme disease coinfection [25] .
Most patients were treated with doxycycline, which has been reported to reduce symptoms and complications in adults [1] and remains the recommended treatment for children of all ages [14] . For the few patients with probable disease who did not receive treatment, we found no adverse outcomes. It remains unclear if doxycycline is beneficial in reducing symptoms, length of illness, or preventing severe complications in children. Thus, it would be prudent to prescribe doxycycline for patients who present with suspected HGA until further studies can assess its necessity.
In summary, HGA seems to be an emerging infection in children. Clinicians should maintain a high index of suspicion in areas of endemicity because the symptoms are nonspecific, and children are unlikely to have the same laboratory anomalies seen in adults. PCR is a rapid, sensitive, and specific way to diagnose infection. Although it seems that most children have mild disease, treatment with doxycycline is recommended because outcomes in children who do not receive treatment remain unknown. We expect that with continued use of PCR to confirm the diagnosis, characterization of HGA and the risks for severe disease in children will be improved. 
